Europe Malaria Treatment Market Forecast to 2030

At 27.0% CAGR, Europe Malaria Treatment Market is Speculated to be Worth US$ 3,060.97 Million by 2030, says the Research Team

According to the Research Team research, the Europe malaria treatment market was valued at US$ 451.69 million in 2022 and is expected to reach US$ 3,060.97 million by 2030, registering a CAGR of 27.0% from 2022 to 2030. Growing strategic initiatives by market players and increasing prevalence of malaria are among the critical factors attributed to the Europe malaria treatment market expansion.

A few major players operating in the malaria treatment market are increasingly focusing on the adoption of various strategies such as product innovations, launches, and approvals; R&D investments; and mergers and acquisitions in order to remain competitive. A few of these initiatives are mentioned below:

In 2023, The R21/Matrix-M malaria vaccine is included in the WHO’s list of prequalified vaccines. Following the recommendations of the Malaria Policy Advisory Group and the WHO Strategic Advisory Group of Experts (SAGE) on Immunization, the WHO recommended its introduction in October 2023 to prevent malaria in children. Prequalification is a requirement for UNICEF to purchase vaccinations and for Gavi, the Vaccine Alliance, to provide financial support for their deployment, which means that more children will have access to vaccines as a crucial tool in the fight against malaria.

In December 2021, Zydus Cadila announced the plan to develop its antimalarial drug ZY19489 with Medicines for Malaria Venture, which received US FDA approval. According to the company, the Phase I trial of ZY19489 demonstrated a long half-life and the potential for a single-dose cure for malaria. In a separate malaria challenge trial, strong antimalarial activity was displayed after a single oral dose of ZY19489.

In January 2021, GSK, PATH, and Bharat Biotech (BBIL) declared that a product transfer agreement was signed for the malaria vaccine RTS,S/AS01E. The agreement included transferring the manufacturing of the RTS,S antigen portion of the vaccine and granting a license for all rights related to the malaria vaccine to BBIL. GSK retains production of the vaccine adjuvant (AS01E) and supplies it to BBIL.

In May 2020, ADVANZ PHARMA Corp. Limited acquired Correvio Pharma Corp, a specialty pharmaceutical company. Under the acquisition, ADVANZ PHARMA achieved an immediate and direct commercial presence in France, Germany, Italy, Spain, and the Benelux region.

Therefore, the abovementioned strategic initiatives by the market players are expected to provide growth opportunities for the malaria treatment market in the coming years.

On the contrary, availability of counterfeit antimalarial drugs followed by subsequent drug resistance hurdles the growth of Europe malaria treatment market.

Based on treatment, the Europe malaria treatment market is categorized into generic drugs, originators, vaccines, and others. The generic drugs segment held 42.7% share of Europe malaria treatment market in 2022, amassing US$ 192.93 million. It is projected to garner US$ 1,284.26 million by 2030 to expand at 26.7% CAGR during 2022-2030.

In terms of route of administration, the Europe malaria treatment market is bifurcated into oral and parenteral. The oral segment held 71.5% share of Europe malaria treatment market in 2022, amassing US$ 322.84 million. It is projected to garner US$ 2,158.80 million by 2030 to expand at 26.8% CAGR during 2022-2030.

By distribution channel, the Europe malaria treatment market is categorized into direct tender, hospital pharmacies, retail pharmacies, online pharmacies, and others. The direct tender segment held 45.2% share of Europe malaria treatment market in 2022, amassing US$ 204.33 million. It is projected to garner US$ 1,390.25 million by 2030 to expand at 27.1% CAGR during 2022-2030.

Based on country, the Europe malaria treatment market has been categorized into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Our regional analysis states that France captured 37.5% share of Europe malaria treatment market in 2022. It was assessed at US$ 169.45 million in 2022 and is likely to hit US$ 1,125.26 million by 2030, exhibiting a CAGR of 26.7% during 2022-2030.

Key players operating in the Europe malaria treatment market are Cipla Ltd, Sun Pharmaceutical Industries Ltd, Sanofi SA, GSK Plc, Novartis AG, Pfizer Inc, and Lupin Ltd, among others.

In May 2021, Novartis reaches milestone delivery of 1 billion courses of antimalarial treatment.

In October 2022, Pfizer completes acquisition of global blood therapeutics.

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe malaria treatment market
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the Europe malaria treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Europe malaria treatment market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

1. Introduction
1.1 the Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights – Malaria
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Malaria Treatment Market – Key Industry Dynamics
4.1 Key Market Drivers:
4.1.1 Increasing Prevalence of Malaria
4.2 Market Restraints
4.2.1 Availability of Counterfeit Antimalarial Drugs Followed by Subsequent Drug Resistance
4.3 Market Opportunities
4.3.1 Growing Strategic Initiatives by Market Players
4.4 Future Trends
4.4.1 Extending Pipeline of New Drugs and Vaccines
4.5 Impact Analysis
5. Malaria Treatment Market – Europe Market Analysis
5.1 Europe Malaria Treatment Market Revenue (US$ million), 2022 – 2030
6. Europe Malaria Treatment Market – Revenue and Forecast to 2030 – by Treatment
6.1 Overview
6.2 Europe Malaria Treatment Market Revenue Share, by Treatment 2022 & 2030 (%)
6.3 Vaccines
6.3.1 Overview
6.3.2 Vaccines Market Revenue and Forecast to 2030 (US$ Mn)
6.4 Generic Drugs
6.4.1 Overview
6.4.2 Generic Drugs Market Revenue and Forecast to 2030 (US$ Mn)
6.5 Originators
6.5.1 Overview
6.5.2 Originators Market Revenue and Forecast to 2030 (US$ Mn)
6.6 Others
6.6.1 Overview
6.6.2 Others Market Revenue and Forecast to 2030 (US$ Mn)
7. Europe Malaria Treatment Market – Revenue and Forecast to 2030 – by Route of Administration
7.1 Overview
7.2 Europe Malaria Treatment Market Revenue Share, by Route of Administration 2022 & 2030 (%)
7.3 Oral
7.3.1 Overview
7.3.2 Oral: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Parenteral
7.4.1 Overview
7.4.2 Parenteral: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
8. Europe Malaria Treatment Market – Revenue and Forecast to 2030 – by Distribution Channel
8.1 Overview
8.2 Europe Malaria Treatment Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
8.3 Direct Tender
8.3.1 Overview
8.3.2 Direct Tender: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Hospital Pharmacies
8.4.1 Overview
8.4.2 Hospital Pharmacies: Malaria Market – Revenue and Forecast to 2030 (US$ Million)
8.4.2.1.1 Malaria Treatment Market, by Hospital Pharmacies
8.5 Retail Pharmacies
8.5.1 Overview
8.5.2 Retail Pharmacies: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
8.5.2.1.1 Malaria Treatment Market, by Retail Pharmacies
8.6 Online Pharmacies
8.6.1 Overview
8.6.2 Online Pharmacies: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
9. Europe Malaria Treatment Market – Country Analysis
9.1 Europe Malaria Treatment Market, Revenue and Forecast to 2030
9.1.1 Overview
9.1.1.1 Europe: Malaria Treatment Market, by Countries
9.1.1.2 France
9.1.1.3 Overview
9.1.1.3.1 France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
9.1.1.3.2 France: Malaria Treatment Market, by Treatment
9.1.1.3.3 France: Malaria -Malaria Treatment Market, by Route of Administration
9.1.1.3.4 France: Malaria Treatment Market, by Distribution Channel
9.1.1.3.4.1 France: Malaria Treatment Market, by Hospital Pharmacies
9.1.1.3.4.2 France: Malaria Treatment Market, by Retail Pharmacies
9.1.1.4 UK
9.1.1.5 Overview
9.1.1.5.1 UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
9.1.1.5.2 UK: Malaria Treatment Market, by Treatment
9.1.1.5.3 UK: Malaria -Malaria Treatment Market, by Route of Administration
9.1.1.5.4 UK: Malaria Treatment Market, by Distribution Channel
9.1.1.5.4.1 UK: Malaria Treatment Market, by Hospital Pharmacies
9.1.1.5.4.2 UK: Malaria Treatment Market, by Retail Pharmacies
9.1.1.6 Italy
9.1.1.7 Overview
9.1.1.7.1 Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
9.1.1.7.2 Italy: Malaria Treatment Market, by Treatment
9.1.1.7.3 Italy: Malaria -Malaria Treatment Market, by Route of Administration
9.1.1.7.4 Italy: Malaria Treatment Market, by Distribution Channel
9.1.1.7.4.1 Italy: Malaria Treatment Market, by Hospital Pharmacies
9.1.1.7.4.2 Italy: Malaria Treatment Market, by Retail Pharmacies
9.1.1.8 Germany
9.1.1.9 Overview
9.1.1.9.1 Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
9.1.1.9.2 Germany: Malaria Treatment Market, by Treatment
9.1.1.9.3 Germany: Malaria -Malaria Treatment Market, by Route of Administration
9.1.1.9.4 Germany: Malaria Treatment Market, by Distribution Channel
9.1.1.9.4.1 Germany: Malaria Treatment Market, by Hospital Pharmacies
9.1.1.9.4.2 Germany: Malaria Treatment Market, by Retail Pharmacies
9.1.1.10 Spain
9.1.1.11 Overview
9.1.1.11.1 Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
9.1.1.11.2 Spain: Malaria Treatment Market, by Treatment
9.1.1.11.3 Spain: Malaria -Malaria Treatment Market, by Route of Administration
9.1.1.11.4 Spain: Malaria Treatment Market, by Distribution Channel
9.1.1.11.4.1 Spain: Malaria Treatment Market, by Hospital Pharmacies
9.1.1.11.4.2 Spain: Malaria Treatment Market, by Retail Pharmacies
9.1.1.12 Rest of Europe
9.1.1.13 Overview
9.1.1.13.1 Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
9.1.1.13.2 Rest of Europe: Malaria Treatment Market, by Treatment
9.1.1.13.3 Rest of Europe: Malaria -Malaria Treatment Market, by Route of Administration
9.1.1.13.4 Rest of Europe: Malaria Treatment Market, by Distribution Channel
9.1.1.13.4.1 Rest of Europe: Malaria Treatment Market, by Hospital Pharmacies
9.1.1.13.4.2 Rest of Europe: Malaria Treatment Market, by Retail Pharmacies
10. Malaria Treatment Market Industry Landscape
10.1 Overview
10.2 Growth Strategies in the Malaria Treatment Market
10.3 Inorganic Growth Strategies
10.3.1 Overview
10.4 Organic Growth Strategies
10.4.1 Overview
11. Company Profiles
11.1 Cipla Ltd
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Sun Pharmaceutical Industries Ltd
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Sanofi SA
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 GSK Plc
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Novartis AG
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Pfizer Inc
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Service
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Lupin Ltd
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
12. Appendix
12.1 About Us
12.2 Glossary of Terms

Table 1. Malaria Treatment Market Segmentation
Table 2. Malaria Drugs/Vaccine/Compounds Under Clinical Development
Table 3. Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 4. Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 5. France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 6. France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 7. France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 8. France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 9. France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 10. UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 11. UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 12. UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 13. UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 14. UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 15. Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 16. Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 17. Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 18. Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 19. Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 20. Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 21. Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 22. Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 23. Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 24. Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 25. Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 26. Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 27. Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 28. Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 29. Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 30. Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 31. Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 32. Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 33. Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 34. Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 35. Recent Inorganic Growth Strategies in the Malaria Treatment Market
Table 36. Recent Organic Growth Strategies in the Malaria Treatment Market
Table 37. Glossary of Terms, Malaria Treatment Market
 

Figure 1. Malaria Treatment Market – Key Industry Dynamics
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. Europe Malaria Treatment Market Revenue (US$ million), 2022 – 2030
Figure 4. Europe Malaria Treatment Market Revenue Share, by Treatment 2022 & 2030 (%)
Figure 5. Vaccines Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 6. Generic Drugs Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 7. Originators Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 8. Others Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 9. Europe Malaria Treatment Market Revenue Share, by Route of Administration 2022 & 2030 (%)
Figure 10. Oral: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Parenteral: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Europe Malaria Treatment Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
Figure 13. Direct Tender: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Hospital Pharmacies: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Retail Pharmacies: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Online Pharmacies: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Others: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Europe Malaria Treatment Market, By Country, 2022 ($Mn)
Figure 19. Europe: Malaria Treatment Market, By Key Countries, 2022 and 2030 (%)
Figure 20. France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 21. UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 22. Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 23. Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 24. Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 25. Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 26. Growth Strategies in the Malaria Treatment Market